- Home
- ERAS vs ITRG Comparison
ERAS vs ITRG Comparison
Compare ERAS & ITRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ERAS
- ITRG
- Stock Information
- Founded
- ERAS 2018
- ITRG 1997
- Country
- ERAS United States
- ITRG Canada
- Employees
- ERAS N/A
- ITRG N/A
- Industry
- ERAS Biotechnology: Pharmaceutical Preparations
- ITRG Precious Metals
- Sector
- ERAS Health Care
- ITRG Basic Materials
- Exchange
- ERAS Nasdaq
- ITRG Nasdaq
- Market Cap
- ERAS 439.7M
- ITRG 497.8M
- IPO Year
- ERAS 2021
- ITRG N/A
- Fundamental
- Price
- ERAS $2.86
- ITRG $2.99
- Analyst Decision
- ERAS Buy
- ITRG Strong Buy
- Analyst Count
- ERAS 6
- ITRG 2
- Target Price
- ERAS $3.50
- ITRG $4.00
- AVG Volume (30 Days)
- ERAS 1.3M
- ITRG 2.4M
- Earning Date
- ERAS 11-12-2025
- ITRG 11-12-2025
- Dividend Yield
- ERAS N/A
- ITRG N/A
- EPS Growth
- ERAS N/A
- ITRG N/A
- EPS
- ERAS N/A
- ITRG 0.08
- Revenue
- ERAS N/A
- ITRG $219,125,000.00
- Revenue This Year
- ERAS N/A
- ITRG $939.47
- Revenue Next Year
- ERAS N/A
- ITRG $6.60
- P/E Ratio
- ERAS N/A
- ITRG $37.52
- Revenue Growth
- ERAS N/A
- ITRG N/A
- 52 Week Low
- ERAS $1.01
- ITRG $0.79
- 52 Week High
- ERAS $3.30
- ITRG $3.49
- Technical
- Relative Strength Index (RSI)
- ERAS 69.19
- ITRG 51.81
- Support Level
- ERAS $2.21
- ITRG $2.84
- Resistance Level
- ERAS $2.90
- ITRG $3.08
- Average True Range (ATR)
- ERAS 0.20
- ITRG 0.21
- MACD
- ERAS 0.04
- ITRG 0.01
- Stochastic Oscillator
- ERAS 96.19
- ITRG 52.92
About ERAS Erasca Inc.
Erasca Inc is a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's product pipeline includes; Naporafenib, a pan-RAF inhibitor with first-in-class potential in NRASm melanoma, RAS Q61X tissue agnostic solid tumors, and other RAS/MAPK pathway-driven tumors, and ERAS-007 (oral ERK1/2 inhibitor) and ERAS-601 (oral SHP2 inhibitor), which target downstream and upstream nodes, respectively, of the RAS/MAPK pathway.
About ITRG Integra Resources Corp.
Integra Resources Corp is a precious metals exploration and development company in the Great Basin of the Western USA. Integra is currently focused on advancing its two flagship oxide heap leach projects: the past-producing DeLamar Project located in southwestern Idaho and the Nevada North Project, comprised of the Wildcat and Mountain View deposits, located in northwestern Nevada. The company also holds a portfolio of prospective early-stage exploration projects in Idaho, Nevada, and Arizona.